Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Chemical & Pharmaceutical Bulletin|July 3, 2020
Discovery of a Novel Class of State-Dependent Na<sub>V</sub>1.7 Inhibitors for the Treatment of Neuropathic PainKyosuke Tanaka, Hiroyuki Kobayashi, Sayaka Suzuki, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Potent and Orally Bioavailable GPR142 Agonists as Novel Insulin Secretagogues for the Treatment of Type 2 DiabetesNarihiro Toda, Xiaolin Hao, Yasuyuki Ogawa, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|March 2, 2016
Three-month risk-benefit profile of anticoagulation after stroke with atrial fibrillation: The SAMURAI-Nonvalvular Atrial Fibrillation (NVAF) studyShoji Arihiro, Kenichi Todo, Masatoshi Koga, et al.
Cerebrovascular Diseases (Basel, Switzerland)|March 30, 2018
Associations between Pre-Admission Risk Scores and Two-Year Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients with Non-Valvular Atrial FibrillationKeisuke Tokunaga, Hiroshi Yamagami, Masatoshi Koga, et al.
Journal of the American Heart Association|January 30, 2019
Prior Anticoagulation and Short- or Long-Term Clinical Outcomes in Ischemic Stroke or Transient Ischemic Attack Patients With Nonvalvular Atrial FibrillationKeisuke Tokunaga, Masatoshi Koga, Ryo Itabashi, et al.
Cerebrovascular Diseases (Basel, Switzerland)|November 11, 2020
Left Atrial Size and Ischemic Events after Ischemic Stroke or Transient Ischemic Attack in Patients with Nonvalvular Atrial FibrillationKeisuke Tokunaga, Masatoshi Koga, Sohei Yoshimura, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|June 5, 2018
Two-Year Outcomes of Anticoagulation for Acute Ischemic Stroke With Nonvalvular Atrial Fibrillation - SAMURAI-NVAF StudySohei Yoshimura, Masatoshi Koga, Shoichiro Sato, et al.
Pageof 4